捷信医药 (834294.OC)

+ 收藏

资产负债表(捷信医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
关 闭
完整财报对比
2019年年报2019年中报2018年年报2018年中报
上市前/上市后 上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表
流动资产:
 货币资金(元) 8,130,479.134,743,974.832,238,645.69738,674.55
  其中:交易性金融资产(元) 4,110,000.00---
 应收票据及应收账款(元) 23,208,482.8119,270,199.2020,792,777.8818,847,406.98
  其中:应收账款(元) 23,208,482.8119,270,199.20--
 预付款项(元) 348,977.21414,810.24302,142.98156,638.83
 应收利息(元) ---
 其他应收款(元) 310,736.00389,338.17378,210.03533,526.78
 存货(元) 737,177.24337,806.69391,295.38215,710.40
 其他流动资产(元) -5,900,000.00920,727.50182,000.00
 流动资产合计(元) 36,845,852.3931,056,129.1325,023,799.4620,673,957.54
非流动资产:
 固定资产(元) 648,168.75583,697.03256,348.40251,577.81
 递延所得税资产(元) 108,983.36121,704.23128,767.74103,011.62
 非流动资产合计(元) 757,152.11705,401.26385,116.14354,589.43
资产总计(元) 37,603,004.5031,761,530.3925,408,915.6021,028,546.97
流动负债:
 短期借款(元) 5,000,000.005,000,000.002,000,000.002,000,000.00
 应付票据及应付账款(元) 2,473,255.421,654,189.361,320,886.141,652,620.84
  其中:应付账款(元) 2,473,255.421,654,189.361,320,886.14-
 预收款项(元) 81,620.009,937.00--
 应付职工薪酬(元) 3,054,895.672,509,692.722,175,506.1022,976.90
 应交税费(元) 1,604,294.811,245,552.871,187,972.72914,085.41
 应付利息(元) ---
 其他应付款(元) 2,337.079,695.361,630.8244,470.11
 流动负债合计(元) 12,216,402.9710,429,067.316,685,995.784,634,153.26
非流动负债:
 长期应付款(元) 17,691.10147,856.4773,329.6497,658.76
 非流动负债合计(元) 17,691.10147,856.4773,329.6497,658.76
负债合计(元) 12,234,094.0710,576,923.786,759,325.424,731,812.02
所有者权益(或股东权益):
 实收资本或股本(元) 20,000,000.0020,000,000.0020,000,000.0020,000,000.00
 资本公积(元) 12,169,494.6311,026,587.8910,634,731.3110,302,659.64
 未分配利润(元) -6,800,584.20-9,841,981.28-11,985,141.13-14,005,924.69
 归属于母公司股东权益合计(元) 25,368,910.4321,184,606.6118,649,590.1816,296,734.95
 股东权益合计(元) 25,368,910.4321,184,606.6118,649,590.1816,296,734.95
负债和股东权益合计(元) 37,603,004.5031,761,530.3925,408,915.6021,028,546.97
公告日期 2020-04-082019-08-202019-04-032018-07-30
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院